We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

2,266 hedge funds and large institutions have $176B invested in Thermo Fisher Scientific in 2022 Q3 according to their latest regulatory filings, with 116 funds opening new positions, 927 increasing their positions, 863 reducing their positions, and 102 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 116 | Existing positions closed: 102

13% more call options, than puts

Call options by funds: $1.47B | Put options by funds: $1.3B

7% more repeat investments, than reductions

Existing positions increased: 927 | Existing positions reduced: 863

0.97% more ownership

Funds ownership: 87.64%88.62% (+0.97%)

1% less funds holding

Funds holding: 2,2812,266 (-15)

5% less capital invested

Capital invested by funds: $186B → $176B (-$9.79B)

6% less funds holding in top 10

Funds holding in top 10: 253238 (-15)

Holders
2,266
Holders Change
-15
Holders Change %
-0.66%
% of All Funds
39.04%
Holding in Top 10
238
Holding in Top 10 Change
-15
Holding in Top 10 Change %
-5.93%
% of All Funds
4.1%
New
116
Increased
927
Reduced
863
Closed
102
Calls
$1.47B
Puts
$1.3B
Net Calls
+$166M
Net Calls Change
+$177M
Name Holding Trade Value Shares
Change
Change in
Stake
MM
976
Meridian Management
Arkansas
$2.97M +$85.1K +152 +3%
STAS
977
Strong Tower Advisory Services
Minnesota
$2.96M -$8.95K -16 -0.3%
SAM
978
Sectoral Asset Management
Quebec, Canada
$2.96M
BG
979
Bahl & Gaynor
Ohio
$2.96M -$80.6K -144 -2%
TMAM
980
Tokio Marine Asset Management
Japan
$2.96M +$368K +657 +13%
HTHT
981
Hemenway Trust Hemenway Trust
New Hampshire
$2.94M +$104K +185 +3%
IA
982
IFP Advisors
Florida
$2.93M +$830K +1,483 +9%
BAM
983
Belpointe Asset Management
Nevada
$2.92M +$309K +552 +11%
LWM
984
Laidlaw Wealth Management
New York
$2.91M +$267K +477 +9%
IEFM
985
IQ EQ Fund Management
Ireland
$2.89M -$290K -518 -8%
EBT
986
Enterprise Bank & Trust
Massachusetts
$2.88M -$6.72K -12 -0.2%
SC
987
Solstein Capital
California
$2.85M +$51.5K +92 +2%
HI
988
Handelsinvest Investeringsforvaltning
Denmark
$2.85M
SIM
989
Stratos Investment Management
Ohio
$2.85M -$306K -547 -9%
LCM
990
Laurion Capital Management
New York
$2.83M +$2.02M +3,603 +183%
AS
991
Altshuler Shaham
Israel
$2.82M +$417K +746 +16%
EHWM
992
Eads & Heald Wealth Management
Georgia
$2.79M -$106K -190 -3%
PR
993
Payden & Rygel
California
$2.79M +$1.12M +2,000 +57%
RCM
994
Regency Capital Management
Hawaii
$2.77M -$47K -84 -2%
ATPW
995
Ashton Thomas Private Wealth
Arizona
$2.75M +$36.4K +65 +1%
MGWM
996
Marks Group Wealth Management
Minnesota
$2.75M +$12.9K +23 +0.4%
RC
997
Roundview Capital
New Jersey
$2.75M +$54.3K +97 +2%
MC
998
Moors & Cabot
Massachusetts
$2.74M -$163K -291 -5%
LBC
999
Lawrence B. Cohen
$2.73M -$449K -803 -13%
AP
1000
Antipodes Partners
Australia
$2.73M +$3.01M +5,381 New

TMO Hedge Fund Activity: Q3 2022 in Review

2,266 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2022, worth a combined $176B — down 5.3% from $186B a quarter earlier.

Buyers outnumbered sellers: 116 funds opened new TMO positions and 102 closed out — a net gain of 14 holders — while 927 added to existing stakes and 863 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $795M. The largest seller was T. Rowe Price Associates, cutting an estimated $2.12B.

  • 2,266 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2022, down from 2,281 in Q2 2022.
  • Funds reported $176B of Thermo Fisher Scientific stock for Q3 2022, down 5.3% quarter-over-quarter.
  • 116 funds opened new Thermo Fisher Scientific positions in Q3 2022 and 102 closed out, a net change of +14 holders.
  • The largest Thermo Fisher Scientific buyer in Q3 2022 was Janus Henderson Group, an estimated $795M added.
  • The largest Thermo Fisher Scientific seller in Q3 2022 was T. Rowe Price Associates, an estimated $2.12B sold.

Based on aggregated 13F filings for Q3 2022.